APA (7th ed.) Citation

Eken, E., Güneyin, E. A., Büyükkurt, E., Yıldız, F., Bilici, M., & Ayman, C. D. (2026). Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors. Current Oncology, 33(6), 302. https://doi.org/10.3390/curroncol33060302

Chicago Style (17th ed.) Citation

Eken, Emre, Emel Ayvaz Güneyin, Elif Büyükkurt, Faruk Yıldız, Mehmet Bilici, and Canan Dinar Ayman. "Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors." Current Oncology 33, no. 6 (2026): 302. https://doi.org/10.3390/curroncol33060302.

MLA (9th ed.) Citation

Eken, Emre, et al. "Prognostic Value of Neutrophil Percentage–Albumin Ratio in Patients with Advanced Melanoma Treated with Immune Checkpoint Inhibitors." Current Oncology, vol. 33, no. 6, 2026, p. 302, https://doi.org/10.3390/curroncol33060302.